Teikoku Pharma USA Announces FDA Accepts Aricept(R) Patch (Donepezil Transdermal System) NDA For Review
Links shared publicly online about this topic.
- 857total visits
Teikoku Pharma USA Announces FDA Accepts Aricept(R) Patch (Donepezil Transdermal System) NDA For Review
View full resource at medicalnewstoday.com
Tags: Alzheimer's Disease Medication, Drug, Pharma, FDA, Aricept
Most Recently Shared on September 21, 2010 at 12:05 pm By:
Teikoku Pharma USA Announces FDA Accepts Aricept(R) Patch (Donepezil Transdermal System) NDA For Review http://mnt.to/3K3F #regulatory
FDA Accepts Aricept, Patch (Donepezil Transdermal System) NDA For Review - QualityPoint Technologies
qualitypointtech.net — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a new weekly transdermal patch of Aricept,, a leading medication for the treatment of Alzheimer's disease. The company developed the weekly Aricept(r) patch based on a license agreement executed between Teikoku Pharma USA, Inc. and Eisai Co., Ltd. (Eisai) in February 2009. The acceptance of the NDA indic” View full resource at qualitypointtech.net
Most Recently Shared on September 18, 2010 at 8:13 pm By:
FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA For Review: Teikoku Pharma USA, Inc., an internat... http://bit.ly/cojyJC
FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA For Review
medicalnewstoday.com — “Teikoku Pharma USA, Inc., an international specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for a” View full resource at medicalnewstoday.com
Most Recently Shared on September 18, 2010 at 2:05 pm By:
FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA For Review http://mnt.to/3JZZ #stress
Advertisement
